TABLE 3.
Association between clarithromycin susceptibility and cagA status, age, place of birth, and prior treatment
| Characteristic | No. (%) of patients |
|||
|---|---|---|---|---|
| Total (n = 117) | Clarithromycin susceptible (n = 75) | Clarithromycin resistant (n = 34) | Discrepant (n = 8) | |
| Children | 60 | 30 (50.0) | 24 (40.0) | 6 (10.0) |
| Adults | 57 | 45 (78.9) | 10 (17.5) | 2 (3.5) |
| Spanish | 89 | 53 (59.6) | 30 (33.7) | 6 (6.7) |
| Not Spanish | 28 | 22 (78.6) | 4 (14.3) | 2 (7.1) |
| Prior treatment | 24 | 8 (33.3) | 14 (58.3) | 2 (8.3) |
| No prior treatment | 93 | 66 (71.0) | 20 (21.5) | 7 (7.5) |